SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 28, 2004
OraSure Technologies, Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-16537 | 36-4370966 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
| 220 East First Street Bethlehem, Pennsylvania |
18015-1360 | |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: 610-882-1820
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 – Entry Into a Material Definitive Agreement
OraSure Technologies, Inc. (the “Company”) and Comerica Bank (“Comerica”) are parties to a Loan and Security Agreement, dated as of September 10, 2002, as amended (the “Loan Agreement”), pursuant to which Comerica has provided the Company with $10.9 million in credit facilities, including a $4.0 million revolving working capital line of credit (the “Revolving Line”) which had a maturity date of November 9, 2004. On September 27, 2004, the Company executed a letter agreement with Comerica (the “Letter Agreement”) extending the maturity date of the Revolving Line to April 30, 2005. A copy of the Letter Agreement is attached as Exhibit 10 to this Form 8-K.
Item 7.01 – Regulation FD Disclosure
On September 28, 2004, the Company issued a press release announcing that an expedited trial has been ordered in the Company’s patent infringement lawsuit against Schering-Plough Healthcare Products, Inc. A copy of the press release is attached as Exhibit 99 to this Form 8-K and is incorporated herein by reference.
Item 9.01 – Financial Statements and Exhibits
(c) Exhibits
| Exhibit Number |
Description | |
| 10 | Letter Agreement, executed September 27, 2004, between OraSure Technologies, Inc. and Comerica Bank. | |
| 99 | Press release, dated September 28, 2004, announcing that an expedited trial has been ordered in the Company’s patent infringement lawsuit against Schering-Plough Healthcare Products, Inc. | |
Signatures
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ORASURE TECHNOLOGIES, INC. | ||||
| Date: September 28, 2004 |
By: |
/s/ Jack E. Jerrett | ||
| Jack E. Jerrett Senior Vice President, General Counsel and Secretary | ||||
Index to Exhibits
| Exhibit No. |
Description | |
| 10 | Letter Agreement, executed September 27, 2004, between OraSure Technologies, Inc. and Comerica Bank. | |
| 99 | Press release, dated September 28, 2004, announcing that an expedited trial has been ordered in the Company’s patent infringement lawsuit against Schering-Plough Healthcare Products, Inc. | |